Search research articles
Contact Us
Filters
Showing results (351-360 of 364) with videos related to
Page
of 37
Sort By:
Cancer Cell
|
July 19, 2002
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
Louise M Kelly, Jin-Chen Yu, Christina L Boulton, et al.
Nature Cell Biology
|
May 2, 2001
PDGF-D, a new protease-activated growth factor
W J LaRochelle, M Jeffers, W F McDonald, et al.
Blood
|
May 28, 2010
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma
Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, et al.
Scientific Reports
|
May 2, 2024
Multiscale and multimodal imaging for three-dimensional vascular and histomorphological organ structure analysis of the pancreas
Gabriel Alexander Salg, Verena Steinle, Jonas Labode, et al.
Gastroenterology
|
September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice
Pouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
JCI Insight
|
August 14, 2025
Photon and particle radiotherapy induce redundant modular chemotaxis of human lymphocytes
Joscha A Kraske, Michael M Allers, Aleksei Smirnov, et al.
Frontiers in Digital Health
|
October 9, 2024
Lessons learned from a multimodal sensor-based eHealth approach for treating pediatric obsessive-compulsive disorder
Carolin S Klein, Karsten Hollmann, Jan Kühnhausen, et al.
Circulation
|
April 14, 2012
High prevalence of respiratory ciliary dysfunction in congenital heart disease patients with heterotaxy
Nader Nakhleh, Richard Francis, Rachel A Giese, et al.
Nature Medicine
|
February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Elisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Science Advances
|
March 23, 2022
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
Thomas Walle, Joscha A Kraske, Boyu Liao, et al.
Page
of 37
Search research articles
Search
Showing results (351-360 of 364) with videos related to
Sort By:
Page
of 37
Cancer Cell
|
July 19, 2002
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
Louise M Kelly, Jin-Chen Yu, Christina L Boulton, et al.
Nature Cell Biology
|
May 2, 2001
PDGF-D, a new protease-activated growth factor
W J LaRochelle, M Jeffers, W F McDonald, et al.
Blood
|
May 28, 2010
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma
Hiroshi Ikeda, Teru Hideshima, Mariateresa Fulciniti, et al.
Scientific Reports
|
May 2, 2024
Multiscale and multimodal imaging for three-dimensional vascular and histomorphological organ structure analysis of the pancreas
Gabriel Alexander Salg, Verena Steinle, Jonas Labode, et al.
Gastroenterology
|
September 1, 2016
Expression of DRD2 Is Increased in Human Pancreatic Ductal Adenocarcinoma and Inhibitors Slow Tumor Growth in Mice
Pouria Jandaghi, Hamed S Najafabadi, Andrea S Bauer, et al.
JCI Insight
|
August 14, 2025
Photon and particle radiotherapy induce redundant modular chemotaxis of human lymphocytes
Joscha A Kraske, Michael M Allers, Aleksei Smirnov, et al.
Frontiers in Digital Health
|
October 9, 2024
Lessons learned from a multimodal sensor-based eHealth approach for treating pediatric obsessive-compulsive disorder
Carolin S Klein, Karsten Hollmann, Jan Kühnhausen, et al.
Circulation
|
April 14, 2012
High prevalence of respiratory ciliary dysfunction in congenital heart disease patients with heterotaxy
Nader Nakhleh, Richard Francis, Rachel A Giese, et al.
Nature Medicine
|
February 9, 2016
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Elisa M Noll, Christian Eisen, Albrecht Stenzinger, et al.
Science Advances
|
March 23, 2022
Radiotherapy orchestrates natural killer cell dependent antitumor immune responses through CXCL8
Thomas Walle, Joscha A Kraske, Boyu Liao, et al.
Page
of 37